Semax

Semax is a drug produced and prescribed mostly in Russia and Ukraine for a broad range of disorders but predominantly for its purported nootropic, neuroprotective and neurorestorative properties. Semax is a heptapeptide, synthetic analogue of an ACTH (4-10) fragment of corticotropin, of the following structure: Met-Glu-His-Phe-Pro-Gly-Pro. Based on one of the endogenous neuropeptides regulating the functions of the central nervous system. The compound has not been evaluated by the FDA. It is unscheduled in the US and legal to import by private citizens for personal use.

Semax has undergone extensive study in Russia and is on the Russian “List of Vital & Essential Drugs” approved by the RF Government on December 7, 2011 N 2199, ATC code N06BX. Medical uses for Semax include treatment of strokes, TIA (Transient Ischemic Attack), memory and cognitive disorders, peptic ulcers, optic nerve disease and to boost the immune system.